Literature DB >> 17971832

A unique case of reversion to normal size of a maternal premutation FMR1 allele in a normal boy.

Elisabetta Tabolacci1, Maria Grazia Pomponi, Roberta Pietrobono, Pietro Chiurazzi, Giovanni Neri.   

Abstract

Fragile X syndrome (FXS) is caused mostly by expansion and subsequent methylation of the CGG repeat in the 5'UTR of the FMR1 gene, resulting in silencing of the gene, absence of FMRP and development of the FXS phenotype. The expansion also predisposes the CGG repeat and the flanking regions to further instability that may lead to mosaics between a full mutation and a premutation or, rarely, a normal or deleted allele. Here, we report on a 10-year-old boy with no FXS phenotype, who has a normal CGG tract, although he inherited the maternal expanded allele that causes FXS in his two brothers. Southern blotting demonstrated that the mother carries a premutation allele ( approximately 190 CGG), whereas the propositus shows a normal 5.2 kb fragment after HindIII digestion and a smaller 2.2 kb fragment after double HindIII-EagI digestion, without any apparent mosaicism in peripheral blood leukocytes. PCR and sequence analysis of the FMR1 5'UTR revealed an allele of 43 repeats, with two interspersed AGG triplets in position 10 and 25 and an exceptional CCG triplet in position 17. This latter creates an abnormal EagI site compatible with the smaller 2.2 kb fragment observed with Southern blotting. Haplotype analysis proved that the rearranged allele originated from the maternal expanded allele. To the best of our knowledge, this is the first non-mosaic case of reduction in the CGG tract of the FMR1 gene, resulting in a normal allele.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17971832     DOI: 10.1038/sj.ejhg.5201949

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  12 in total

1.  Mutsβ generates both expansions and contractions in a mouse model of the Fragile X-associated disorders.

Authors:  Xiao-Nan Zhao; Daman Kumari; Shikha Gupta; Di Wu; Maya Evanitsky; Wei Yang; Karen Usdin
Journal:  Hum Mol Genet       Date:  2015-09-29       Impact factor: 6.150

2.  The transcription-coupled repair protein ERCC6/CSB also protects against repeat expansion in a mouse model of the fragile X premutation.

Authors:  Xiao-Nan Zhao; Karen Usdin
Journal:  Hum Mutat       Date:  2015-04       Impact factor: 4.878

3.  Size and methylation mosaicism in males with Fragile X syndrome.

Authors:  Poonnada Jiraanont; Madhur Kumar; Hiu-Tung Tang; Glenda Espinal; Paul J Hagerman; Randi J Hagerman; Nuanchan Chutabhakdikul; Flora Tassone
Journal:  Expert Rev Mol Diagn       Date:  2017-11       Impact factor: 5.225

4.  Fragile X mosaic male full mutation/normal allele detected by PCR/MS-MLPA.

Authors:  Tihomir Todorov; Albena Todorova; Andrey Kirov; Boyan Dimitrov; Ralph Carvalho; Anders O H Nygren; Iliana Boneva; Vanyo Mitev
Journal:  BMJ Case Rep       Date:  2009-05-18

5.  Clinical utility gene card for: fragile X mental retardation syndrome, fragile X-associated tremor/ataxia syndrome and fragile X-associated primary ovarian insufficiency.

Authors:  Sebastien Jacquemont; Stefanie Birnbaum; Silke Redler; Peter Steinbach; Valérie Biancalana
Journal:  Eur J Hum Genet       Date:  2011-05-04       Impact factor: 4.246

6.  Contraction of fully expanded FMR1 alleles to the normal range: predisposing haplotype or rare events?

Authors:  Nuno Maia; Joana R Loureiro; Bárbara Oliveira; Isabel Marques; Rosário Santos; Paula Jorge; Sandra Martins
Journal:  J Hum Genet       Date:  2016-10-27       Impact factor: 3.172

Review 7.  Recent advances in assays for the fragile X-related disorders.

Authors:  Bruce E Hayward; Daman Kumari; Karen Usdin
Journal:  Hum Genet       Date:  2017-09-02       Impact factor: 4.132

Review 8.  Repeat-mediated genetic and epigenetic changes at the FMR1 locus in the Fragile X-related disorders.

Authors:  Karen Usdin; Bruce E Hayward; Daman Kumari; Rachel A Lokanga; Nicholas Sciascia; Xiao-Nan Zhao
Journal:  Front Genet       Date:  2014-07-17       Impact factor: 4.599

Review 9.  The multiple molecular facets of fragile X-associated tremor/ataxia syndrome.

Authors:  Chantal Sellier; Karen Usdin; Chiara Pastori; Veronica J Peschansky; Flora Tassone; Nicolas Charlet-Berguerand
Journal:  J Neurodev Disord       Date:  2014-07-30       Impact factor: 4.025

10.  EMQN best practice guidelines for the molecular genetic testing and reporting of fragile X syndrome and other fragile X-associated disorders.

Authors:  Valérie Biancalana; Dieter Glaeser; Shirley McQuaid; Peter Steinbach
Journal:  Eur J Hum Genet       Date:  2014-09-17       Impact factor: 4.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.